Ex-Insys Execs Driven By Greed To Bribe Doctors, Jury Hears

Law360, Boston (January 28, 2019, 5:47 PM EST) -- Greed drove Insys Therapeutics Inc.'s wealthy founder and four company executives to spend millions bribing doctors to prescribe an expensive opioid spray, a federal prosecutor said as a closely watched trial began Monday in Boston, with the executives claiming all they did was legally market their drug.

John Kapoor, the company's founder, was on a mission to increase sales of the fentanyl spray Subsys and paid more than $1 million to eight individual prescribers in an attempt to get them to write more prescriptions for the drug, which cost as much as $19,000 per month per patient, Assistant U.S. Attorney David...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!